{
    "nctId": "NCT04428528",
    "briefTitle": "Photoacoustic Imaging for Characterizing Breast Masses and Breast Tumor Response to Neoadjuvant Chemotherapy",
    "officialTitle": "Pilot Study to Evaluate Photoacoustic Imaging for Characterizing Breast Masses and Breast Tumor Response to Neoadjuvant Chemotherapy",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Treatment response correlation between photoacoustic parameters and histopathological measurement.",
    "eligibilityCriteria": "Cohort 1 - Neoadjuvant Chemotherapy Monitoring:\n\nInclusion Criteria:\n\n* Subjects must give appropriate written informed consent prior to participation in the study;\n* Subjects must be able and willing to comply with the safety procedures during the Scanning Period;\n* Subjects must be men and women of between 20 to 80 years of age, inclusive, on the day the Informed Consent Form is signed;\n* Subjects must be receiving neoadjuvant chemotherapy for locally-advanced breast cancer.\n* Biopsy-confirmed diagnosis of locally advanced breast cancer; of all molecular subtypes (ER+/-, PR+/-, HER2+/-).\n\nExclusion Criteria:\n\n* Subjects with a past medical history of abnormalities, significant injury, or medical or surgical procedures (e.g. Silicone/saline implants) involving either breast, exclusive of the lesion at issue;\n* Subjects with any dermatologic abnormalities (including tattoos, open sores, or breached skin) involving either breast;\n* Subjects with a current or past medical history of connective tissue disease;\n* Subjects who are pregnant or lactating;\n* Subjects with an implanted electronic device such as a cardiac pacemaker, defibrillator, or neurological stimulator;\n* Subjects with a history or expectation of significant anxiety associated with undergoing diagnostic evaluations;\n* Subjects with a history of musculoskeletal disease which may predispose them to discomfort during the Scanning Period;\n* Subjects with a known sensitivity to low-power infrared radiation (e.g., as a result of a dermatologic condition); and\n* Subjects, who, in the opinion of the investigator or clinical research coordinator, may not otherwise be appropriate for inclusion into the study.\n\nCohort 2 - Breast Mass Characterization:\n\nInclusion Criteria:\n\n* Subjects must give appropriate written informed consent prior to participation in the study;\n* Subjects must be able and willing to comply with the safety procedures during the Scanning Period;\n* Subjects must be men and women of between 20 to 80 years of age, inclusive, on the day the Informed Consent Form is signed;\n* Subjects must be referred to breast diagnostic clinic for investigation of a breast mass.\n\nExclusion Criteria:\n\n* Subjects with a past medical history of abnormalities, significant injury, or medical or surgical procedures (e.g.,silicone/saline implants) involving either breast, exclusive of the lesion at issue;\n* Subjects with any dermatologic abnormalities (including tattoos, open sores, or breached skin) involving either breast;\n* Subjects with a current or past medical history of connective tissue disease;\n* Subjects who are pregnant or lactating;\n* Subjects with an implanted electronic device such as a cardiac pacemaker, defibrillator, or neurological stimulator;\n* Subjects with a history or expectation of significant anxiety associated with undergoing diagnostic evaluations;\n* Subjects with a history of musculoskeletal disease which may predispose them to discomfort during the Scanning Period;\n* Subjects with a known sensitivity to low-power infrared radiation (e.g., as a result of a dermatologic condition); and\n* Subjects, who, in the opinion of the investigator or clinical research coordinator, may not otherwise be appropriate for inclusion into the study.",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}